Skip to content

Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness

Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness in Experienced Resistance Trained Individuals.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01793779
Enrollment
40
Registered
2013-02-18
Start date
2012-12-31
Completion date
2013-04-30
Last updated
2013-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Damage

Brief summary

Study Objectives 1. Compare beta-hydroxy-beta-methylbutyrate free acid (HMB-FA) to cold water immersion on performance recovery from an acute bout of high intensity resistance exercise. 2. Compare HMB-FA + Cold water immersion to HMB-FA or cold water immersion. 3. Examine the effect of these recovery modalities on markers of muscle damage, inflammation and immune function. Subjects Subjects (men and women, 18 - 35 y) with at least one year of resistance training experience will be recruited. Subjects will be randomly divided into one of four groups: a cold water immersion group (CW), HMB-FA, CW+HMB-FA and a control group (CT). Study Protocol Subjects will report to the Human Performance Laboratory (HPL) on four separate occasions. On the first visit (T1) subjects will be tested for maximal strength \[one repetition-maximum (1-RM)\] on the squat, dead lift and barbell lunge exercises.\] On their second visit (T2) subjects will perform a lower body resistance exercise session consisting of four sets of the squat, dead lift and barbell lunge exercises. All subjects will then report back to the HPL at 24- (T3) and 48-hours (T4) post-exercise. During T3 and T4, subjects will perform four sets of the squat exercise only using the same loading pattern and rest interval length as T2. Following the T2 and T3 workouts subjects in CT will undergo no treatment; subjects in CW will be required to sit in a whirlpool tub for 10-min up to their umbilicus in water at 50° F - 54° F (10° C - 12° C); subjects in HMB-FA will be provided the supplement 30 min prior each workout and CW+HMB-FA will be administered together at time points describe above. Statistical Analysis Statistical evaluation of performance and biochemical changes will be accomplished using a repeated measures analysis of variance (ANOVA).

Interventions

DIETARY_SUPPLEMENTbeta-hydroxy-beta-methylbutyrate free acid (HMB-FA)
DIETARY_SUPPLEMENTPlacebo

Sponsors

Metabolic Technologies Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* At least one-year of resistance training experience * Free of any physical limitations (determined by health and activity questionnaire). * Between the ages of 18 and 35

Exclusion criteria

* Inability to perform physical exercise (determined by health and activity questionnaire) * Taking any other nutritional supplement or performance enhancing drug (determined from health and activity questionnaire). * Any chronic illness that causes continuous medical care * Taking any type of prescription or over-the-counter medication, having any chronic illness causing you to seek medical care, pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Maximal muscle strengthChange from baseline over 48 hours post-exercise.The 1-RM tests will be performed to assess maximal muscle strength.

Secondary

MeasureTime frameDescription
Muscle damageChange from baseline over 48 hours post-exercise.Serum creatine kinase and myoglobin concentrations will be analyzed as markers of muscle damage.

Other

MeasureTime frameDescription
Muscle sorenessChange from baseline over 48-hours post-exercise.Subjects will be asked to rate their degree of lower body muscle soreness using a 15-cm visual analog scale (VAS).
Lower body powerChange from baseline over 48 hours post-exercise.Lower body power during the squat exercise protocol will be measured each repetition with a Tendo™ Power Output Unit.
Immune MarkersChange from baseline over 48 hours post-exercise.Immune (IL-6, IL-10, Macrophage inflammatory protein-1β, tumor necrosis factor-α) markers will be analyzed.
C-reactive proteinChange from baseline over 48 hours post-exercise.The Inflammatory marker, C-reactive protein, will be analyzed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026